-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Poster II

Symposia: Thrombosis and Anticoagulation: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Natasha Szuber, MD, MSc1,2,3, Michael Harnois2*, Robert Delage, MD2,4, Shireen Sirhan, MD2,5 and Lambert Busque, MD1,2,3

1University of Montreal, Montreal, QC, Canada
2Groupe Québécois de Recherche en LMC-NMP/Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Quebec Research Group (GQR LMC-NMP), Montreal, QC, Canada
3Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
4CHU de Québec - Université Laval, Quebec, QC, Canada
5Segal Cancer Center, Jewish General Hospital, Montreal, QC, Canada

Danielle Fredman, MD1,2*, Rotem McNeil, MD1,2*, Ofir Eldar, MD1,2*, Avi Leader, MD2,3*, Anat Gafter-Gvili, MD1,2,3* and Tomer Avni, MD1,2*

1Department of Medicine A, Rabin medical center, Beilinson hospital, Petah Tikva, Israel
2Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
3Davidoff Cancer Center, Rabin Medical Center, Institute of Hematology, Petah Tikva, Israel

Romy de Laat-Kremers, PhD1*, Marina Loizou, PhD2*, Scott Tawaga, MD, PhD2*, Jacob H. Rand, MD, PhD3, Bas de Laat, MD, PhD4 and Maria T DeSancho, MD, MSc5

1Department of Data Analysis and Artificial Intelligence, Synapse Research Institute, Maastricht, Netherlands
2Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York
3Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
4Department of Functional Coagulation, Synapse Research Institute, Maastricht, Netherlands
5Division of Hematology and Medical Oncology, Department of Medicine. Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY

Thomas Delate, PhD, MS1*, Nathan Clark, PharmD2*, Ashok Pai, MD3,4,5, Jodi B Loyles, PharmD6* and Kari Olson, PharmD7*

1Kaiser Permanente National Pharmacy, Aurora
2Department of Pharmacy, Kaiser Permanente, Aurora, CO
3Oakland and Richmond Medical Centers, Kaiser Permanente, Oakland, CA
4Oakland Medical Center, UC Davis Medical Center, Oakland, CA
5The Permanente Medical Group, Oakland, CA
6Kaiser Permanente Northern California, Oakland
7Kaiser Permanente Colorado, Aurora

Maria T DeSancho, MD, MSc1, Erin Suvar, Nurse Practitioner2*, Jonathan C. Roberts, MD3, Michael D Tarantino, MD4, Jarren Santos5* and Michael Recht, MD, PhD, MBA6,7,8

1Division of Hematology and Medical Oncology, Department of Medicine. Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
2Division of Hematology-Oncology, Department of Medicine. Weill Cornell Medicine/New York Presbyterian Hospital, New York
3Bleeding and Clotting Disorders Institute. University of Illinois College of Medicine at Peoria, Peoria, IL
4Professor of Pediatrics and Medicine, The Bleeding and Clotting Disorders Institute, University of Illinois College of Medicine-Peoria, Peoria, IL
5American Thrombosis Hemostasis Network, Iowa City
6American Thrombosis and Hemostasis Network, Rochester, NY
7The Hemophilia Center, Oregon Health & Science University, Portland, OR
8Oregon Health and Science University, Portland, OR

Meghan McCormick, MD, MS1, Molly Mack, MD2 and Frederico Xavier, MD, MS3

1Department of Pediatric Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
2Pediatric Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
3Children's Hospital of Pittsburgh, University of Pittsburgh and Hemophilia Center of Western PA, Pittsburgh, PA

Rushad Patell, MBBS1, Minggao Shi, PhD2*, Michael A. Grosso, MD3*, Anil Duggal, MD2*, Harry Büller4*, Gary E. Raskob, PhD5 and Jeffrey I. Zwicker, MD1

1Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA
2Daiichi Sankyo Pharma Development, Basking Ridge, NJ
3Daiichi-Sankyo Pharma Development, Basking Ridge, NJ
4Amsterdam University Medical Centers, Amsterdam, NLD
5Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK

Sang-A Kim, MD1*, Ji Yun Lee1*, Jeong-Ok Lee, MD Ph.D.1 and Soo-Mee Bang, MD, PhD2

1Division of Hemato-Oncology, Department of Internal medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)
2Division of Hemato-Oncology, Department of Internal medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea

Cecilia Becattini, MD1,2*, Ludovica Anna Cimini, MD3*, Giorgio Bassanelli, MD4*, Aldo P Maggioni, MD5*, Fulvio Pomero, MD6*, Ilaria Lobascio, MD7*, Daniela P Pomata, MD8*, Maria P Ruggeri, MD9*, Beniamino Zalunardo, MD10*, Anna Novelli, MD11*, Giancarlo Agnelli, MD1*, Lucio Gonzini, MD12* and Michele M Gulizia, MD13*

1Internal Vascular and Emergency Medicine Stroke Unit, University of Perugia, Perugia, Italy
2University of Perugia, Perugia, ITA
3Internal, Vascular and Emergency Medicine– Stroke Unit, University of Perugia, Perugia, Italy
4Department of Cardiology, Ospedale Alessandro Manzoni, Lecco, Italy
5ANMCO Research Center, Heart Care Foundation, Florence, Italy
6Division of Internal Medicine, Michele and Pietro Ferrero Hospital, Verduno, Italy
7UOC Cardiologia, Ospedale Civile, Arzignano, Italy
8UOC Medicina d'Urgenza e PS, Ospedale Policlinico S. Orsola-Malpighi, Bologna, Italy
9U.O.C. Medicina d’Urgenza e Pronto Soccorso, AO San Giovanni Addolorata, Roma, Italy
10UOC Angiologia, P.O. Castelfranco Veneto, Castelfranco Veneto, Italy
11PS e Medicina d'Urgenza, Ospedali Riuniti, Livorno, Italy
12ANMCO Research Center, Heart Care Foundation, Firenze, Italy
13Division of Cardiology, Garibaldi-Nesima Hospital, Catania, Italy

Parwana Hussaini, PharmD1*, Trine-Lise Larsen, MD2,3*, Waleed Ghanima, MD4,5 and Anders Erik Astrup Dahm, MD, PhD4,6*

1Faculty of Medicine, University of Oslo, Oslo, Norway
2Institute of clinical medicine, University of Oslo,, Oslo, Norway
3Department of Haematology, Akershus University Hospital, Lørenskog, Norway
4Institute of Clinical Medicine, University of Oslo, Oslo, Norway
5Clinic of Internal Medicine, Østfold Hospital, Grålum, Norway
6Section of Haematology, Akershus University Hospital,, Lørenskog, Norway

Camille Simard, MD1*, Isabelle Malhamé, MD, MSc, FRCPC2,3*, Antonios Douros, MD, PhD4*, Kristian B. Filion, PhD5*, Haim Abenhaim, MD, MPH, FRCSC6,7* and Vicky Tagalakis, MD, FRCPC1,8

1General Internal Medicine, Jewish General Hospital, Montreal, QC, Canada
2General Internal Medicine, McGill University Healthcare Centre, Montreal, QC, Canada
3Research Institute of the McGill University Health Centre, Montreal, QC, Canada
44. Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
5Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada
6Jewish General Hospital, Division of Obstetrics and Gynecology, Montreal, QC, Canada
7Jewish General Hospital, Centre for Clinical Epidemiology and Community Studies, Montreal, QC, Canada
8Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, QC, Canada

Kwadwo Osei Bonsu, PharmD1,2*, Stephanie W Young, PharmD3,4*, Tiffany Lee, BSc(Pharm), Pharm.D1,4*, Rufaro S Chitsike, MBChB, MMed(Haem), FCPath(Haem), Cert Clin(Haem)5,6 and Hai V Nguyen, PhD1*

1School of Pharmacy, Memorial University, St. John's, NF, Canada
2School of Pharmacy, School of Pharmacy, St. John's, NL, Canada
3School of Pharmacy, Memorial University, St John's, NL, Canada
4Pharmacy Department, Eastern Health, St. John's, NF, Canada
5Division of Medicine (Hematology), Memorial University, St John's, NF, Canada
6Division of Hematology, Eastern Health, St. John's, NF, Canada

Kyra L McCarty, DO1*, Vincent S Staggs, PhD2*, Erin E Bolen, MD3*, Justin K Massey, MD3* and Lauren E Amos, MD4

1Center for Cancer and Blood Disorders, UT Southwestern Medical Center, Dallas, TX
2Biostatistics and Epidemiology Core, Children's Mercy Hospital, Kansas City, MO
3Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO
4Department of Hematology/Oncology/BMT, Children's Mercy Hospital, Kansas City, MO

Sarina Levy-Mendelovich, MD1,2,3*, Shelly Soffer, MD4*, Eyal Klang, MD2*, Assaf Arie Barg, MD5*, Walter Ageno, MD6*, Gili Kenet, MD7,8 and Omri Cohen, MD6,9*

1National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel
2Sheba Medical Center, Talpiot Leadership Program, Tel Hashomer, Israel
3Amalia Biron Research Institute of Thrombosis and Hemostasis, Tel Aviv University, Tel Hashomer, Israel
4Assuta Medical Center, Ashdod, Israel
5National Hemophilia Center and Coagulation Center and Amalia Biron Res Inst of Thromb & Hemost and Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Tel Hashomer Medical Center, Ramat Gan, Israel
6Department of Medicine and Surgery, University of Insubria, Varese, Italy
7The National Hemophilia Center, and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel
8The Amalia Biron Thrombosis Research Institute, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel
9National Hemophilia Center, Coagulation Unit and Amalia Biron Res Inst of Thromb and Hemost, Sheba Medical Center, Tel Hashomer, Israel

Omri Cohen, MD, BS1,2*, Assaf Arie Barg, MD3,4*, Ulrike Nowak-Göttl, MD, PhD5*, Reina Valle6*, Lucia Mazzolai7*, Gregorio Tiberio8*, Sebastian Schellong9*, Andris Skride10*, Mª del Valle Morales11*, Manuel Monreal, MD, PhD12* and Gili Kenet, MD13,14

1National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Israel
2Amalia Biron Research Institute of Thrombosis and Hemostasis, Tel Aviv University, Tel Hashomer, Israel
3Department of Pediatric Hematology-Oncology, Tel Hashomer Medical Center, Ramat Gan, Israel
4Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
5Institute of Clinical Chemistry, University Hospital Schleswig-Holstein, Kiel, Germany
6Department of Internal Medicine. Hospital Sierrallana. Santander. Spain., Santander, Spain
7Service of Angiology, Lausanne University Hospital, Lausanne, Switzerland
8Department of Internal Medicine. Hospital Virgen del Camino. Pamplona. Navarra. Spain., Navara, Spain
9Hospital Dresden Friedrichstadt, Dresden, DEU
10Department of Cardiology. Ospedale Pauls Stradins Clinical University Hospital. Riga Stradiņš University. Riga. Latvia, Riga, Latvia
11Department of Internal Medicine. Hospital del Tajo. Madrid. Spain., Madrid, Spain
12Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM - Universidad Católica San Antonio de Murcia. Spain. CIBER Enfermedades Respiratorias (CIBERES). Madrid. Spain, Madrid, Spain
13The Amalia Biron Thrombosis Research Institute, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel
14Israel National Hemophilia Center and Thrombosis Institute, Sheba Medical Center, Tel Hashomer, Israel

Stephanie W Young, PharmD1,2*, Michael Coombs, Pharmacy Student3*, Kwadwo Osei Bonsu, PharmD3*, Tiffany Lee, BSc(Pharm), Pharm.D2,3*, Hai V Nguyen, PhD3* and Rufaro S Chitsike, MBChB, MMed(Haem), FCPath(Haem), Cert Clin(Haem)4,5

1School of Pharmacy, Memorial University, St John's, NL, Canada
2Pharmacy Department, Eastern Health, St. John's, NF, Canada
3School of Pharmacy, Memorial University, St. John's, NF, Canada
4Division of Hematology, Eastern Health, St. John's, NF, Canada
5Division of Medicine (Hematology), Memorial University, St John's, NF, Canada

Vivian Irizarry Gatell, MD1, Michael Bacchus2*, Edward De Leo, MD3, Yang Zhang4*, Carrie Lagasse, PharmD5*, Anna Y Khanna, MD6*, Neil Harris, MD, MBBChir7 and Marc Stuart Zumberg, MD8

1Division of Hematology and Oncology, University of Florida, Gainesville
2College of Medicine, University of Florida, Gainesville, FL
3Division of Hematology and Oncology, University of Florida, Gainesville, FL
4Department of Medicine, University of Florida, Gainesville, FL
5Department of Pharmacology, University of Florida, Gainesville, FL
6Department of Neurology, University of Florida, Gainesville
7University of Florida, Gainesville, FL
8Division of Hematology/Oncology, University of Florida, Gainesville, Gainesville, FL

Gianna M. Guzzardo, MD1, Cynthia Sabo, MSN, RN, CPNP1* and Madhvi Rajpurkar, MD1,2

1Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, MI
2Children’s Hospital of Michigan/Carman and Ann Adams Department of Pediatrics/Central Michigan University/Wayne State University, Detroit, MI

Danielle Carole Roy, BSc1*, Amin Zahrai, MSc1*, Ronda Lun, MD1,2*, Tzu-Fei Wang, MD, MPH1,3,4, Steven Hawken, PhD, MSc, BSc1,2*, Ranjeeta Mallick, PhD, MSc, BSc1,2*, Dylan Burger, PhD2,4* and Philip S. Wells, MD, MSc, FRCPC1,2,4

1School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada
2The Ottawa Hospital Research Institute, Ottawa, ON, Canada
3Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada
4Department of Medicine, University of Ottawa, Ottawa, ON, Canada

*signifies non-member of ASH